Skip to main content

Table 5 Survival outcomes in NPC patients with positive PLNC between NCT + CCRT group and CCRT group

From: Can neoadjuvant chemotherapy improve survival in stage T3-4N1 nasopharyngeal carcinoma? A propensity matched analysis

Variables

NCT + CCRT group (N = 18)

CCRT group (N = 15)

Pvalue

5-year OS

84.8%

81.3%

0.470

5-year LRFS

93.3%

72.2%

0.157

5-year DRFS

85.6%

74.6%

0.607

5-year RFS

72.7%

55.6%

0.304

  1. Abbreviations: NPC Nasopharyngeal carcinoma; NCT Neoadjuvant chemoradiotherapy; CCRT Concurrent chemoradiotherapy; PLNC Pretreatment lymph node condition; OS Overall survival; LRFS Locoregional recurrence-free survival; DRFS Distant recurrence-free survival; RFS Recurrence-free survival
Back to article page

Radiation Oncology

ISSN: 1748-717X

Contact us